Prevalence of erectile dysfunction in HTLV-1-infected patients and its association with overactive bladder
- PMID: 20189229
- PMCID: PMC2866747
- DOI: 10.1016/j.urology.2009.11.041
Prevalence of erectile dysfunction in HTLV-1-infected patients and its association with overactive bladder
Abstract
Objectives: To determine the prevalence of erectile dysfunction (ED) in human T-cell lymphotropic virus type I (HTLV-I)-infected patients, and its association with overactive bladder (OB).
Methods: In a cross-sectional study, 111 male patients with positive serology for HTLV-I (by enzyme-linked immunosorbent assay and Western blot) were examined between October 2003 and December 2006. Exclusion criteria were age <18 and >80 years, other neurological diseases, penile prosthesis, neoplasm, and psychological and mental disease. Patients were evaluated by a urologist and neurologist. ED was determined by application of the abridged form of 5-item International Index of Erectile Function (IIEF-5). ED was defined as IIEF-5 <or= 21. OB was determined by International Continence Society criteria. Using the Expanded Disability Status Scale (EDSS) to determine disautonomy status, a neurologist classified all patients as either asymptomatic carriers (EDSS = 0), "oligosymptomatic myelopathy" (EDSS > 0 e <or= 2), or HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP); (EDSS > 2). Diagnosis of HAM/TSP was performed according to World Health Organization recommendations.
Results: Of the total of 111 patients, 6 were excluded and 105 were analyzed. The mean age was 48 +/- 10.7 years. ED was observed in 55.2%. ED was documented in all patients who had HAM/TSP, in 79% of the group with EDSS > 0 and <or=2, and in 35.9% of HTLV-1-infected individuals with EDSS = 0. OB was detected in 93.75%, 33.3%, and 4.6%, respectively. Moreover, there was an association observed between ED and OB.
Conclusions: ED is a frequent disease in HTLV-I-infected individuals, and the prevalence is directly correlated to the degree of neurological disability measured by EDSS. ED was strongly associated with OB symptoms.
Copyright 2010 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Evolution of erectile dysfunction in individuals infected with human T-lymphotropic virus 1: a prospective cohort study.J Sex Med. 2023 Feb 27;20(3):269-276. doi: 10.1093/jsxmed/qdac050. J Sex Med. 2023. PMID: 36751985
-
Hormonal and Psychogenic Risk Factors for Erectile Dysfunction in Men with HTLV-1.J Sex Med. 2019 Nov;16(11):1763-1768. doi: 10.1016/j.jsxm.2019.07.028. Epub 2019 Sep 11. J Sex Med. 2019. PMID: 31521570
-
Erectile dysfunction and HTLV-I infection: a silent problem.Int J Impot Res. 2005 Jul-Aug;17(4):364-9. doi: 10.1038/sj.ijir.3901335. Int J Impot Res. 2005. PMID: 15875060
-
Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.Rev Neurol (Paris). 2012 Mar;168(3):257-69. doi: 10.1016/j.neurol.2011.12.006. Epub 2012 Mar 7. Rev Neurol (Paris). 2012. PMID: 22405461 Review.
-
Progression of HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis after Pregnancy: A Case Series and Review of the Literature.Pathogens. 2024 Aug 28;13(9):731. doi: 10.3390/pathogens13090731. Pathogens. 2024. PMID: 39338922 Free PMC article. Review.
Cited by
-
HAM/TSP and major depression: the role of age.Braz J Infect Dis. 2015 May-Jun;19(3):314-8. doi: 10.1016/j.bjid.2014.12.003. Epub 2015 Jan 27. Braz J Infect Dis. 2015. PMID: 25636187 Free PMC article.
-
Intrarater and interrater agreement and reliability of vestibular evoked myogenic potential triggered by galvanic vestibular stimulation (galvanic-VEMP) for HTLV-1 associated myelopathy testing.PLoS One. 2018 Sep 27;13(9):e0204449. doi: 10.1371/journal.pone.0204449. eCollection 2018. PLoS One. 2018. PMID: 30261002 Free PMC article.
-
Onabotulinumtoxin type A improves lower urinary tract symptoms and quality of life in patients with human T cell lymphotropic virus type 1 associated overactive bladder.Braz J Infect Dis. 2018 Mar-Apr;22(2):79-84. doi: 10.1016/j.bjid.2017.10.009. Epub 2018 Feb 17. Braz J Infect Dis. 2018. PMID: 29462596 Free PMC article.
-
Clinical manifestations in individuals with recent diagnosis of HTLV type I infection.J Clin Virol. 2011 May;51(1):54-8. doi: 10.1016/j.jcv.2011.02.004. Epub 2011 Mar 8. J Clin Virol. 2011. PMID: 21388871 Free PMC article.
-
Intrafamilial Transmission of HTLV-1 and HTLV-2 in Indigenous Peoples of the Brazilian Amazon: Molecular Characterization and Phylogenetic Analysis.Viruses. 2024 Sep 26;16(10):1525. doi: 10.3390/v16101525. Viruses. 2024. PMID: 39459860 Free PMC article.
References
-
- Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;1(8488):1031–1032. - PubMed
-
- Osame M. Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP) J Neurovirol. 2002;8(5):359–364. - PubMed
-
- Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, et al. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058–6068. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous